This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: University of Florida Research Foundation Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Steven Douglas Bruner: Innovator in Cancer Research
Introduction
Steven Douglas Bruner is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 2 patents, Bruner is recognized for his advancements in the treatment of leukemia and other cancers.
Latest Patents
Bruner's latest patents include groundbreaking methods for killing leukemia cells through the administration of recombinant Y3 proteins. His work on a fungal glycan binding protein demonstrates antiviral and anticancer activity. The subject invention pertains to compositions and methods for preparing and using recombinant proteins based on the fungal Y3 protein to control plant and animal viruses and microbes. Additionally, he has developed methods using compositions comprising recombinant Y3 proteins to diagnose, prevent, and treat cancer diseases based on the interaction of recombinant Y3 protein with glycans expressed on cancer cells.
Career Highlights
Bruner is affiliated with the University of Florida Research Foundation Inc., where he continues to push the boundaries of cancer research. His innovative approaches have the potential to transform treatment methodologies and improve patient outcomes.
Collaborations
Bruner has collaborated with esteemed colleagues such as Peilan Zhang and Yousong Ding. Their combined expertise enhances the research efforts and contributes to the advancement of cancer treatment strategies.
Conclusion
Steven Douglas Bruner is a pioneering inventor whose work in cancer research is making a significant impact. His innovative patents and collaborations are paving the way for new treatment options for leukemia and other cancers.